EXAM 3 PHARMACOLOGY SPRING 2017
2026-2027 100% VERIFIED QUESTIONS AND ANSWERS — AGRADE
Resource Origin: Exam 3 Pharmacology Spring 2017 (Chamberlain University)
Academic Standard: Nurse Practitioner (NP) Board-Style Curriculum
Verification Level: 100% Verified Answers & Explanations (AGRADE Only)
Target Domain: Advanced Clinical Pharmacology, Adverse Interventions & Safety Triage
Compiled Release: August 2026 (2026-2027 Clinical Syllabus Alignment)
Notice: This compiled manual is 100% unconfidential and serves strictly as an educational study guide and verified practice
database. Published in compliance with local nursing practice guidelines and clinical pharmacological standards. The document
layout maintains an elegant, high-contrast, double-column and single-column hybrid design for maximum readability.
,EXAM 3 PHARMACOLOGY SPRING 2017 2026-2027 CLINICAL UPDATE — AGRADE
STUDY BLUEPRINT & CURRICULAR MAPPING
This study manual features exactly 100 board-style questions designed to map 100% onto the core concepts of the Exam 3
Pharmacology Spring 2017 resource. It expands the initial 50-item question set into a double-volume test bank (100 Questions)
where each core pharmacology question is paired with a highly complex clinical application or safety scenario.
Clinical Domain Target Focus Questions
Gastrointestinal System Ondansetron, GERD, antacids, PPIs, Metoclopramide, 1–2, 5–6, 11–12, 17–18, 29–30,
laxatives 51–52, 55–56, 79–80, 81–82,
89–90
Cardiovascular System Sildenafil, Nitroglycerin, Digoxin, metoprolol, atenolol, 3–4, 7–10, 21–22, 24, 31–32,
prazosin 43–44, 47–50, 63–64, 67–68,
73–74, 91–94
Pulmonary Therapeutics Fluticasone, guaifenesin, albuterol, beclomethasone, 13–14, 15–16, 23, 27–28, 39–40,
theophylline, montelukast, Duoneb 57–60, 65–66, 71–72, 75–78,
85–86
Hematology & Warfarin, broad-spectrum antibiotics, Heparin toxicity & 41–42, 53–54, 97–98
Anticoagulation antidotes
Fluid & Electrolytes Potassium replacement, Thiazides, Spironolactone, 19–20, 33–34, 69–70, 99–100
diuretics
Pharmacology Calculations Reconstitution mathematics, dosage IM volumes 45–46
Systemic Side Effects (EPS, Phenothiazines (promethazine), Statins (myopathy/LFTs) 35–38
etc.)
Autonomic & Atropine, Lomotil, ipratropium, BPH, Glaucoma 61–62, 87–88
Anticholinergics
Advanced Pharmacology study manual & test solutions Page 2 of 102
,EXAM 3 PHARMACOLOGY SPRING 2017 2026-2027 CLINICAL UPDATE — AGRADE
SECTION: GASTROINTESTINAL — ONDANSETRON (ZOFRAN) PREGNANCY PATIENT EDUCATION
Learning Objective: Evaluate patient understanding of safe drug sourcing and quality control during pregnancy.
Question 1: A pregnant client who is experiencing severe morning sickness is prescribed Ondansetron (Zofran) 4
mg PO. During discharge teaching, the nurse assesses the patient's understanding. Which statement by the client
indicates a critical need for further education?
A. I should take this medication exactly as prescribed to control my severe nausea.
B. I can purchase cheaper, generic Zofran freely on the internet to save on healthcare costs.
C. I should notify my healthcare provider if I experience any rapid heartbeats or dizziness.
D. I will store this medication in its original container away from heat and moisture.
ANSWER ■: B — I can purchase cheaper, generic Zofran freely on the internet to save on healthcare costs.
Explanation:
Ondansetron (Zofran) is a prescription-only 5-HT3 receptor antagonist used to manage severe nausea. Purchasing generic Zofran
'freely' over the internet bypasses critical pharmaceutical quality control and medical oversight, presenting a severe risk of receiving
counterfeit, contaminated, or subpotent medications that are highly dangerous to both the mother and fetus. Safe medications must only
be obtained from licensed pharmacies. Option A is incorrect because compliance is expected. Option C is incorrect because Zofran can
prolong the QT interval, and tachycardia/dizziness are important reportable side effects. Option D is incorrect because proper storage is
a standard, correct practice.
Key Concept: Pregnant patients must never purchase prescription-only antiemetics or other medications from unregulated internet
sources due to the extreme danger of counterfeits to fetal safety.
■■ COMMON MISTAKE:
Students often focus only on the physiological side effects of antiemetics, overlooking the critical nursing responsibility to counsel patients against
purchasing medications from unverified online sources.
DIFFICULTY: Cognitive Level: Evaluating | MSC: Client Needs: Safe and Effective Care Environment: Reduction of Risk Potential
Advanced Pharmacology study manual & test solutions Page 3 of 102
, EXAM 3 PHARMACOLOGY SPRING 2017 2026-2027 CLINICAL UPDATE — AGRADE
SECTION: GASTROINTESTINAL — ONDANSETRON (ZOFRAN) CLINICAL CARDIAC SAFETY
Learning Objective: Analyze the physiological cardiac risks associated with high-dose intravenous or oral ondansetron
Question 2: An advanced practice nurse is reviewing the pharmacological profile of a client who is starting on
high-dose Ondansetron (Zofran) for chemotherapy-induced nausea. Which of the following pre-existing patient
conditions represents the most significant cardiac contraindication to this therapy?
A. Controlled chronic essential hypertension
B. Congenital long QT syndrome or a history of torsades de pointes
C. Mild sinus bradycardia with a heart rate of 58 beats per minute
D. History of paroxysmal atrial fibrillation currently in sinus rhythm
ANSWER ■: B — Congenital long QT syndrome or a history of torsades de pointes
Explanation:
Ondansetron (Zofran) causes dose-dependent prolongation of the QT interval on the electrocardiogram (ECG) by blocking myocardial
potassium channels. In patients with congenital long QT syndrome, severe hypokalemia, or a history of torsades de pointes,
ondansetron administration can trigger a fatal ventricular arrhythmia. Mild sinus bradycardia (Option C), paroxysmal atrial fibrillation in
sinus rhythm (Option D), and controlled essential hypertension (Option A) are not absolute contraindications, though cautious monitoring
of electrolytes and baseline ECG is always prudent in cardiac patients.
Key Concept: Ondansetron (Zofran) carries a class risk of QT interval prolongation and is contraindicated in patients with congenital long
QT syndrome or active ventricular dysrhythmias.
■■ COMMON MISTAKE:
Students often confuse the safe profile of ondansetron for general nausea with its potential to cause life-threatening QT prolongation at higher
therapeutic or intravenous doses.
DIFFICULTY: Cognitive Level: Analyzing | MSC: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
Advanced Pharmacology study manual & test solutions Page 4 of 102
2026-2027 100% VERIFIED QUESTIONS AND ANSWERS — AGRADE
Resource Origin: Exam 3 Pharmacology Spring 2017 (Chamberlain University)
Academic Standard: Nurse Practitioner (NP) Board-Style Curriculum
Verification Level: 100% Verified Answers & Explanations (AGRADE Only)
Target Domain: Advanced Clinical Pharmacology, Adverse Interventions & Safety Triage
Compiled Release: August 2026 (2026-2027 Clinical Syllabus Alignment)
Notice: This compiled manual is 100% unconfidential and serves strictly as an educational study guide and verified practice
database. Published in compliance with local nursing practice guidelines and clinical pharmacological standards. The document
layout maintains an elegant, high-contrast, double-column and single-column hybrid design for maximum readability.
,EXAM 3 PHARMACOLOGY SPRING 2017 2026-2027 CLINICAL UPDATE — AGRADE
STUDY BLUEPRINT & CURRICULAR MAPPING
This study manual features exactly 100 board-style questions designed to map 100% onto the core concepts of the Exam 3
Pharmacology Spring 2017 resource. It expands the initial 50-item question set into a double-volume test bank (100 Questions)
where each core pharmacology question is paired with a highly complex clinical application or safety scenario.
Clinical Domain Target Focus Questions
Gastrointestinal System Ondansetron, GERD, antacids, PPIs, Metoclopramide, 1–2, 5–6, 11–12, 17–18, 29–30,
laxatives 51–52, 55–56, 79–80, 81–82,
89–90
Cardiovascular System Sildenafil, Nitroglycerin, Digoxin, metoprolol, atenolol, 3–4, 7–10, 21–22, 24, 31–32,
prazosin 43–44, 47–50, 63–64, 67–68,
73–74, 91–94
Pulmonary Therapeutics Fluticasone, guaifenesin, albuterol, beclomethasone, 13–14, 15–16, 23, 27–28, 39–40,
theophylline, montelukast, Duoneb 57–60, 65–66, 71–72, 75–78,
85–86
Hematology & Warfarin, broad-spectrum antibiotics, Heparin toxicity & 41–42, 53–54, 97–98
Anticoagulation antidotes
Fluid & Electrolytes Potassium replacement, Thiazides, Spironolactone, 19–20, 33–34, 69–70, 99–100
diuretics
Pharmacology Calculations Reconstitution mathematics, dosage IM volumes 45–46
Systemic Side Effects (EPS, Phenothiazines (promethazine), Statins (myopathy/LFTs) 35–38
etc.)
Autonomic & Atropine, Lomotil, ipratropium, BPH, Glaucoma 61–62, 87–88
Anticholinergics
Advanced Pharmacology study manual & test solutions Page 2 of 102
,EXAM 3 PHARMACOLOGY SPRING 2017 2026-2027 CLINICAL UPDATE — AGRADE
SECTION: GASTROINTESTINAL — ONDANSETRON (ZOFRAN) PREGNANCY PATIENT EDUCATION
Learning Objective: Evaluate patient understanding of safe drug sourcing and quality control during pregnancy.
Question 1: A pregnant client who is experiencing severe morning sickness is prescribed Ondansetron (Zofran) 4
mg PO. During discharge teaching, the nurse assesses the patient's understanding. Which statement by the client
indicates a critical need for further education?
A. I should take this medication exactly as prescribed to control my severe nausea.
B. I can purchase cheaper, generic Zofran freely on the internet to save on healthcare costs.
C. I should notify my healthcare provider if I experience any rapid heartbeats or dizziness.
D. I will store this medication in its original container away from heat and moisture.
ANSWER ■: B — I can purchase cheaper, generic Zofran freely on the internet to save on healthcare costs.
Explanation:
Ondansetron (Zofran) is a prescription-only 5-HT3 receptor antagonist used to manage severe nausea. Purchasing generic Zofran
'freely' over the internet bypasses critical pharmaceutical quality control and medical oversight, presenting a severe risk of receiving
counterfeit, contaminated, or subpotent medications that are highly dangerous to both the mother and fetus. Safe medications must only
be obtained from licensed pharmacies. Option A is incorrect because compliance is expected. Option C is incorrect because Zofran can
prolong the QT interval, and tachycardia/dizziness are important reportable side effects. Option D is incorrect because proper storage is
a standard, correct practice.
Key Concept: Pregnant patients must never purchase prescription-only antiemetics or other medications from unregulated internet
sources due to the extreme danger of counterfeits to fetal safety.
■■ COMMON MISTAKE:
Students often focus only on the physiological side effects of antiemetics, overlooking the critical nursing responsibility to counsel patients against
purchasing medications from unverified online sources.
DIFFICULTY: Cognitive Level: Evaluating | MSC: Client Needs: Safe and Effective Care Environment: Reduction of Risk Potential
Advanced Pharmacology study manual & test solutions Page 3 of 102
, EXAM 3 PHARMACOLOGY SPRING 2017 2026-2027 CLINICAL UPDATE — AGRADE
SECTION: GASTROINTESTINAL — ONDANSETRON (ZOFRAN) CLINICAL CARDIAC SAFETY
Learning Objective: Analyze the physiological cardiac risks associated with high-dose intravenous or oral ondansetron
Question 2: An advanced practice nurse is reviewing the pharmacological profile of a client who is starting on
high-dose Ondansetron (Zofran) for chemotherapy-induced nausea. Which of the following pre-existing patient
conditions represents the most significant cardiac contraindication to this therapy?
A. Controlled chronic essential hypertension
B. Congenital long QT syndrome or a history of torsades de pointes
C. Mild sinus bradycardia with a heart rate of 58 beats per minute
D. History of paroxysmal atrial fibrillation currently in sinus rhythm
ANSWER ■: B — Congenital long QT syndrome or a history of torsades de pointes
Explanation:
Ondansetron (Zofran) causes dose-dependent prolongation of the QT interval on the electrocardiogram (ECG) by blocking myocardial
potassium channels. In patients with congenital long QT syndrome, severe hypokalemia, or a history of torsades de pointes,
ondansetron administration can trigger a fatal ventricular arrhythmia. Mild sinus bradycardia (Option C), paroxysmal atrial fibrillation in
sinus rhythm (Option D), and controlled essential hypertension (Option A) are not absolute contraindications, though cautious monitoring
of electrolytes and baseline ECG is always prudent in cardiac patients.
Key Concept: Ondansetron (Zofran) carries a class risk of QT interval prolongation and is contraindicated in patients with congenital long
QT syndrome or active ventricular dysrhythmias.
■■ COMMON MISTAKE:
Students often confuse the safe profile of ondansetron for general nausea with its potential to cause life-threatening QT prolongation at higher
therapeutic or intravenous doses.
DIFFICULTY: Cognitive Level: Analyzing | MSC: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
Advanced Pharmacology study manual & test solutions Page 4 of 102
